Lamotrigine was added as a therapeutic option to combat the patient's cognitive deficits and ongoing agitation and stress; it was chosen for its mechanism involving sodium channels as a potential modifier of the patient's ANK3 variation. This evidence concerns the gene ANK3 and Cognitive impairment.